CSIMarket
 

Aspira Women s Health Inc   (AWH)
Other Ticker:  
 

Aspira Women S Health Inc 's Working Capital Per Sales

AWH's Working Capital and Revenue growth



AWH Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change -83.2 % -89.51 % -80.19 % -66.3 % -61.43 %
Y / Y Revenue Change 7 % 20.57 % 22.35 % 16.32 % 24.37 %
Working Capital Per Revenue 0.54 0.91 1.37 2.03 2.78
Total Ranking # 2326 # 2428 # 2816 # 2043 # 96
Seq. Working Capital Change 57.88 % -64.34 % -56.72 % -31.06 % -1.43 %
Seq. Revenue Change -11 % 7.56 % 7.57 % 3.91 % 0.29 %





Comment on AWH's Working Capital Per Revenue in the third quarter 2023
Aspira Women S Health Inc 's Working Capital Per Revenue in the Q3 2023 sequentially fell to 0.54 below the company average.

Within Healthcare sector 77 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Aspira Women S Health Inc Working Capital Per Revenue overall ranking has impoved so far in the Q3 2023 to 2326, from total ranking in the second quarter 2023 at 2428.
Working Capital Per Revenue Ranking
Within: No.
Industry # 1
Sector # 78
S&P 500 # 2326


Working Capital Per Revenue Statistics
High Average Low
6.51
1.83
0.51
(Dec 31 2021)   (Mar 31 2017)



Financial Statements
Aspira Women S Health Inc 's Working Capital $ 3 Millions Visit AWH's Balance sheet
Aspira Women S Health Inc 's Revenues $ 2 Millions Visit AWH's Income Statement
Where are AWH's Sales coming from? Visit AWH's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
G1 Therapeutics Inc   1.49 
Biomerica Inc   1.48 
Intra cellular Therapies Inc   1.48 
Reflect Scientific Inc   1.48 
Beigene ltd   1.47 
Retractable Technologies inc   1.45 
Marker Therapeutics inc   1.39 
Nuwellis Inc   1.37 
Standard Biotools Inc   1.36 
Revance Therapeutics Inc   1.35 
Fennec Pharmaceuticals Inc   1.35 
Tenon Medical Inc   1.34 
Immunogen inc   1.33 
Neuropace Inc   1.32 
Orthopediatrics Corp  1.31 
United Therapeutics Corporation  1.30 
Biocryst Pharmaceuticals Inc   1.30 
Axsome Therapeutics Inc   1.29 
Silk Road Medical Inc   1.27 
Urogen Pharma Ltd   1.26 
Esperion Therapeutics inc   1.25 
Cutera Inc   1.24 
Fibrogen Inc   1.24 
Vbi Vaccines Inc  1.24 
Axonics Inc   1.22 
Voyager Therapeutics Inc   1.22 
Amylyx Pharmaceuticals Inc   1.21 
Ultragenyx Pharmaceutical Inc   1.20 
Guardion Health Sciences Inc   1.20 
Palatin Technologies Inc   1.19 
Date modified: 2023-11-14T22:39:54+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com